<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is a strong connection between <z:mp ids='MP_0001845'>inflammation</z:mp>, altered microRNA (miRNA) expression and <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Longstanding <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel diseases</z:e>-related <z:hpo ids='HP_0002583'>colitis</z:hpo> leads to increased risk for the development of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), while <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is in part driven by the inflammatory microenvironment </plain></SENT>
<SENT sid="2" pm="."><plain>This supports a causative role for <z:mp ids='MP_0001845'>inflammation</z:mp> in colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>miRNAs are a class of small noncoding <z:chebi fb="40" ids="33697">RNAs</z:chebi> that have recently emerged as key players in both <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Some miRNAs act as <z:mp ids='MP_0002501'>inflammatory mediators</z:mp>, others can act as either oncogenes or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressors depending on the cellular environment in which they are expressed </plain></SENT>
<SENT sid="5" pm="."><plain>In particular, miR-21 is an oncogenic miRNA that has been implicated as an inflammatory mediator and may promote <z:mp ids='MP_0001845'>inflammation</z:mp>-associated colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>miRNAs have potential as biomarkers and therapeutic targets in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>They are currently being evaluated as early detection biomarkers and prognostic classifiers </plain></SENT>
<SENT sid="8" pm="."><plain>Polymorphisms in miRNAs and miRNA-binding sites may alter one's risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>This review will focus on the role of <z:mp ids='MP_0001845'>inflammation</z:mp> and miRNAs in colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and discuss the potential for miRNAs and inflammatory genes to be used as biomarkers and therapeutic targets of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>